<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en" article-type="correction">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">OL</journal-id>
<journal-title-group>
<journal-title>Oncology Letters</journal-title>
</journal-title-group>
<issn pub-type="ppub">1792-1074</issn>
<issn pub-type="epub">1792-1082</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/ol.2026.15642</article-id>
<article-id pub-id-type="publisher-id">OL-32-1-15642</article-id>
<article-categories>
<subj-group>
<subject>Corrigendum</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>[Corrigendum] EGFR and ERK activation resists flavonoid quercetin-induced anticancer activities in human cervical cancer cells <italic>in vitro</italic></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Chen</surname><given-names>Xin</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Xu</surname><given-names>Pengli</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Huijun</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Su</surname><given-names>Xiaosan</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Guo</surname><given-names>Lihua</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Zhou</surname><given-names>Xuhong</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Wang</surname><given-names>Junliang</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Huang</surname><given-names>Peng</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Qingzhi</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Sun</surname><given-names>Ruifen</given-names></name>
</contrib>
</contrib-group>
<pub-date pub-type="collection"><month>07</month><year>2026</year></pub-date>
<pub-date pub-type="epub"><day>08</day><month>05</month><year>2026</year></pub-date>
<volume>32</volume>
<issue>1</issue>
<elocation-id>287</elocation-id>
<permissions>
<copyright-statement>Copyright: &#x00A9; Chen et al.</copyright-statement>
<copyright-year>2026</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</license-p></license>
</permissions>
</article-meta>
</front>
<body>
<p>Oncol Lett 22: <related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="corrected-article" vol="22" page="754" id="RA1" xlink:href="10.3892/ol.2021.13015" ext-link-type="doi">754</related-article>, 2021; DOI: 10.3892/ol.2021.13015</p>
<p>Subsequently to the publication of the above paper, an interested reader drew to the authors&#x2019; attention that, concerning the cell invasion assay data shown in <xref rid="f4-ol-32-1-15642" ref-type="fig">Fig. 4B</xref> on p. 7, the &#x2018;0 h&#x2019; panels for the HeLa and SiHa cell lines showed a large overlapping section of data, such that these data appeared to have been derived from the same original source where the results from the two different cell lines were intended to have been portrayed. Additionally, upon performing an independent analysis of the data in this paper in the Editorial Office, it came to light that the Tubulin western bands in the &#x2018;40&#x2019; and &#x2018;80&#x2019;-labelled lanes of <xref rid="f5-ol-32-1-15642" ref-type="fig">Fig. 5C</xref> (for the HeLa cell line experiments) were strikingly similar to the Tubulin bands in the &#x2018;0&#x2019; and &#x2018;20&#x2019;-labelled lanes in Fig. 3E (also for the HeLa cell line experiments).</p>
<p>The authors were able to re-examine their original data, and realized that the data included in <xref rid="f4-ol-32-1-15642" ref-type="fig">Figs. 4B</xref> and <xref rid="f5-ol-32-1-15642" ref-type="fig">5C</xref> were inadvertently selected incorrectly. The revised versions of <xref rid="f4-ol-32-1-15642" ref-type="fig">Figs. 4</xref> and <xref rid="f5-ol-32-1-15642" ref-type="fig">5</xref>, now showing the correct data for the &#x2018;0 h&#x2019; invasion assay data panel for the SiHa cell line and the Tubulin western blots for the HeLa cell line in <xref rid="f5-ol-32-1-15642" ref-type="fig">Fig. 5C</xref>, are shown on the next two pages. The authors regret the errors that were made while compiling the original figures, and are grateful to the editor of <italic>Oncology Letters</italic> for allowing them the opportunity to publish this Corrigendum. Note that the errors in this pair of figures did not have a significant impact on the conclusions reached in this study. All the authors agree with the publication of this corrigendum; furthermore, they apologize to the readership for any inconvenience caused.</p>
</body>
<floats-group>
<fig id="f4-ol-32-1-15642" position="float">
<label>Figure 4.</label>
<caption><p>Que inhibits the migration and invasion of the cervical cancer cell lines. (A) The cells were treated with 0 or 80 &#x00B5;M Que for 0, 24 and 36 h, then the degree of wound healing was measured. (B) In total, &#x007E;10,000 SiHa and HeLa cells were seeded in the Transwell chamber in 200 &#x00B5;l FBS-free medium with the indicated concentration of Que for 48 h. Matrigel was added onto the microporous membrane in advance to simulate the environment of the extracellular matrix was only used for the invasion assay, and then the cells that penetrated the membrane were stained with crystal violet for subsequent examination. n=3. &#x002A;&#x002A;P&#x003C;0.01, &#x002A;&#x002A;&#x002A;P&#x003C;0.001. Que, quercetin.</p></caption>
<alt-text>Que inhibits the migration and invasion of the cervical cancer cell lines. (A) The cells were treated with 0 or 80 &#x00B5;M Que for 0, 24 and 36 h, then the degree of wound healing was measured. (B) In total...</alt-text>
<graphic xlink:href="ol-32-01-15642-g00.jpg"/>
</fig>
<fig id="f5-ol-32-1-15642" position="float">
<label>Figure 5.</label>
<caption><p>Que promotes cervical cancer cell apoptosis and affects the expression levels of apoptosis-related proteins. (A) The cervical cancer cells were treated with Que (0, 40, 80 and 120 &#x00B5;M) for 24 h, then flow cytometry analysis was performed to investigate cell apoptosis and the difference was (B) statistically analyzed. (C) The cervical cancer cell lines were treated with Que (0, 20, 40 and 80 &#x00B5;M) for 36 h, then the protein expression levels were examined using western blot analysis. Tubulin was used as the loading control. n=3. &#x002A;&#x002A;P&#x003C;0.01, &#x002A;&#x002A;&#x002A;P&#x003C;0.001. Que, quercetin.</p></caption>
<alt-text>Que promotes cervical cancer cell apoptosis and affects the expression levels of apoptosis-related proteins. (A) The cervical cancer cells were treated with Que (0, 40, 80 and 120 &#x00B5;M) for 24 h, then...</alt-text>
<graphic xlink:href="ol-32-01-15642-g01.jpg"/>
</fig>
</floats-group>
</article>
